Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice
subject: coronavirus, Public health, covid-19, SARS-CoV-2, Smoking
description: Introduction There has been significant speculation regarding the association between the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pathogen, coronavirus disease (COVID-19) and smoking. We provide an overview of the available literature regarding the association between smoking, risk of SARS-CoV-2 infection, and risk of severe COVID-19 and poor clinical outcomes, with the aim of informing public health policy and practice, particularly in England. Methods Publications were identified utilising a systematic search approach on PUBMED and Google Scholar. Publications presenting a systematic review or meta-analysis considering the association between smoking and SARS-COV-2 infection or COVID-19 outcomes were included. Results Eight studies were identified. One considered the relationship between smoking and the probability of SARS-CoV-2 infection, three considered the association between COVID-19 hospitalisation and smoking history, and six reviewed the association between smoking history and development of severe COVID-19. One study specifically investigated the risk of mortality. The studies considering risk of severe disease indicate that there is a significant association between COVID-19 and current or ever smoking. Conclusions This is a rapidly evolving topic. Current analysis remains limited due to the quality of primary data, although, early results indicate an association between smoking and COVID-19 severity. We highly recommend public health messaging to continue focusing on smoking cessation efforts.
creator: Filippos T. Filippidis, Emily J. Grundy*, Taiba Suddek*, Azeem Majeed, Sophie Coronini-Cronberg
source: Epidemiology and Health
publisher: Korean Society of Epidemiology
date: 2020
coverage: Diseases of the respiratory system, Neoplasms. Tumors. Oncology. Including cancer and carcinogens